Skip to content

Clinical trials

Phase 3 Nervous System Diseases trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Phase: Phase 3 Country / region: Czechia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20131
20143
20151
20161
20191
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Auspex Pharmaceuticals, Inc.2
Ipsen2
PTC Therapeutics2
AstraZeneca1
Baxalta now part of Shire1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases12
Central Nervous System Diseases6
Movement Disorders5
Brain Diseases4
Neurodegenerative Diseases4
Neuromuscular Diseases3
Parkinson Disease3
Parkinsonian Disorders3
Autoimmune Diseases of the Nervous System2
Dyskinesias2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.